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Abstract
Background: Nontypeable Haemophilus influenzae (NTHi) is an important respiratory pathogen implicated as an infectious
trigger in chronic obstructive pulmonary disease, but its molecular interaction with human lung epithelial cells remains unclear.
Herein, we tested that the hypothesis that NTHi induces the expression of cyclooxygenase (COX)-2 and prostaglandin E2
(PGE2) via activation of p38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-kappa B in pulmonary alveolar
epithelial cells.
Methods: Human alveolar epithelial A549 cells were infected with different concentrations of NTHi. The phosphorylation of
p38 MAPK was detected by Western blot analysis, the DNA binding activity of NF-kappa B was assessed by electrophoretic
mobility shift assay (EMSA), and the expressions of COX-1 and 2 mRNA and PGE2 protein were measured by reverse
transcription-polymerase chain reaction (RT-PCR) and enzyme linked immunosorbent assay (ELISA), respectively. The roles of
Toll-like receptor (TLR) 2 and TLR4, well known NTHi recognizing receptor in lung epithelial cell and gram-negative bacteria
receptor, respectively, on the NTHi-induced COX-2 expression were investigated in the HEK293 cells overexpressing TLR2
and TLR4 in vitro and in the mouse model of NTHi-induced pneumonia by using TLR2 and TLR4 knock-out mice in vivo. In
addition, the role of p38 MAPK and NF-kappa B on the NTHi-induced COX-2 and PGE2 expression was investigated by using
their specific chemical inhibitors.
Results: NTHi induced COX-2 mRNA expression in a dose-dependent manner, but not COX-1 mRNA expression in A549
cells. The enhanced expression of PGE2 by NTHi infection was significantly decreased by pre-treatment of COX-2 specific
inhibitor, but not by COX-1 inhibitor. NTHi induced COX-2 expression was mediated by TLR2 in the epithelial cell in vitro and
in the lungs of mice in vivo. NTHi induced phosphorylation of p38 MAPK and up-regulated DNA binding activity of NF-kappa B.
Moreover, the expressions of COX-2 and PGE2 were significantly inhibited by specific inhibitors of p38 MAPK and NF-kappa
B. However, NTHi-induced DNA binding activity of NF-kappa B was not affected by the inhibition of p38 MAPK.
Conclusion: NTHi induces COX-2 and PGE2 expression in a p38 MAPK and NF-kappa B-dependent manner through TLR2 in
lung epithelial cells in vitro and lung tissues in vivo. The full understanding of the role of endogenous anti-inflammatory PGE2 and
its regulation will bring new insight to the resolution of inflammation in pulmonary bacterial infections.
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Background
Nontypeable  Haemophilus influenzae (NTHi) is one of
common and important respiratory pathogens. NTHi
causes otitis media and conductive hearing loss in chil-
dren while pulmonary presence of this facultative intrac-
ellular pathogen is implicated as an infectious trigger in
chronic obstructive pulmonary disease (COPD) in adults
[1,2]. The emergence of antibiotic-resistance strains of
NTHi and the difficulty of development of efficacious vac-
cines urge further efforts to understand the host response
mechanisms involved in NTHi infections.
The respiratory epithelium is an important interface to
environmental microorganisms. In addition to provide a
physical barrier against microbial invasion and contribute
to mucociliary clearance, respiratory epithelial cells are
actively involved in inflammation and host defense of the
lung in multiple ways. In particular, type 2 alveolar epi-
thelial cells (AECs) as a defender of the alveolus are
located in alveoli where they recognize invading patho-
gens by extracellular and intracellular receptors and con-
tribute to host innate immunity [3-5]. Lipid metabolites
of arachidonic acid such as prostaglandins have been
shown to modulate immune and inflammatory responses
[6,7]. Prostaglandin E2 (PGE2) is a product of the
cyclooxygenase (COX) pathway. Two isoforms of COX,
the constitutively expressed COX-1 and the inducible
COX-2, have been identified. PGE2 is commonly thought
to have proinflammatory effects on the pathogenesis of
several inflammatory diseases including rheumatoid
arthritis and periodontitis [7,8]. However, increasing evi-
dence demonstrated that pulmonary PGE2 has a role in
limiting the inflammatory response and tissue repair in
contrast to its counterparts in other organs of the body [7].
The expression of COX-derived PGE2 and its molecular
regulation depend on cell types and stimuli [9]. In the
present study, we showed that NTHi induced COX-2
expression and subsequent PGE2 production via activa-
tion of p38 mitogen-activated protein kinase (MAPK) and
nuclear factor (NF)-kappa B in lung epithelial cells. The
full understanding of the role of pulmonary endogenous
anti-inflammatory mediators such as PGE2 and their reg-
ulation will bring new insight and develop novel treat-
ment aiming at immune modulation.
Methods
Materials
SB203580, SB202190, PDTC, SC560, and NS398 were
purchased from Sigma Chemicals (CA, USA), PGE2 ELISA
kit was from R&D Co. (Minneapolis, USA). All other
chemicals used were of analytical grade and obtained
from commercial sources.
Isolation and identification of bacterial strain
NTHi strain was a clinical isolate from Second Affiliated
Hospital of Medical School, Zhejiang University. The sus-
pectable H. influenzae strains were confirmed by X, V and
X+V factor requirement test, satellite test and API-NH
identification system. Slide serum agglutination test was
performed and the isolated strain was proved to not
agglutinate with all the capsule antiserum of type a, b, c,
d, e, and f. Finally, the isolated strain was identified by
16S rRNA gene amplification and sequencing. NTHi
strain 12 was used for in vitro HEK239 cell experiments
and in vivo mice experiments.
Mice experiments
C57BL/6 and BALB/c mouse strains, background strain
for TLR2 and TLR4 knock-out, respectively, and TLR2 and
TLR4 knock-out mice were used for NTHi-induced COX-2
expression in NTHi-induced pneumonia model in mice in
vivo. C57BL/6 mice were purchased from National Cancer
Institute (NCI, NIH, USA) and TLR2 knock-out mice were
kindly provide by Dr. S. Akira, and TLR4 knock-out mice
were purchased from Jackson Lab. (USA). Under the
anesthesia, wild-type and TLR2 and TLR4 knock-out mice
were intratracheally inoculated with 1 × 107 CFU of NTHi
strain 12. Mice lung tissues were collected 6 h after NTHi
inoculation and mRNA expression of COX-2 was meas-
ured by quantitative RT-PCR (Q-PCR) as described below.
All the animal experiments were approved by the Institu-
tional Animal Care and Use Committee at University of
Rochester.
Cell culture and in vitro experiments
A human alveolar epithelial cell line A549 (ATCC-CCL-
185) was a kind gift from Shanghai ZJ Bio-Tech Co. Ltd.,
China. A549 cells were grown in 75 cm2 polystyrene flasks
with RPMI1640 (HyClone, Tauranga, New Zealand) sup-
plemented with 10% heat-inactivated fetal calf serum
(Gibco, NY, USA). A549 cells were seeded at 1 × 106 cells
per well of 6-well flat-bottom, cell culture plates (Corn-
ing, NY, USA). This produced a confluent monolayer after
overnight incubation at 37°C in a 5% CO2 humidified
atmosphere. After growth medium was replaced by an
antibiotic-free medium, A549 cells (1 × 106 cells/mL)
were infected with NTHi (multiplicity of infection, MOI:
1, 10, 50). Inhibition experiments were carried out by 1 h
pretreatment with the p38 MAPK inhibitor SB203580 (20
µM), SB202190 (10 µM), the NF-kappa B inhibitor PDTC
(40 µM) or the selective COX-1 inhibitor SC560 (5 µM),
COX-2 inhibitor NS398 (10 µM) before bacterial stimula-
tion. Supernatants after incubation were collected and
stored at -70°C freezer for ELISA detection. HEK293 cells,
stably overexpressing pcDNA, TLR2, and TLR4, were
kindly provided by Dr. D.T. Golenbock, and cells were
maintained in Dulbecco's modified Eagle's medium sup-Respiratory Research 2008, 9:16 http://respiratory-research.com/content/9/1/16
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plemented with 10% FBS, 0.5 mg/mL of G418, and 10 µg/
mL of ciprofloxacin (Cellgro, Herndon, VA).
Reverse transcription-polymerase chain reaction (RT-
PCR)
Total RNA was isolated from A549 cells with Trizol Rea-
gent (Invitrogen, CA, USA). For cDNA synthesis, 20 µL RT
mixture containing total RNA 2 µg, dNTP 1 mM/L,
Olig(dt)17 prime 0.2 µg, RNasin 20 U, M-MLV reverse
transcriptase 200 U was incubated at 42°C for 60 min,
then the reverse transcriptase was inactivated at 72°C for
15 min. PCR amplification was performed on a PE2400
cycler (Perkin-Elmer, Massachusetts, USA). Omiga 2.0
software (Oxford Molecular, Oxford, UK) was employed
to design oligonucleotide primers specific for human
COX-1, COX-2 and GAPDH (an internal control). COX-1:
forward: 5' AGTACCGCAAGAGGTTTGGC 3', reverse: 5'
GCCGTCTTGACAATGTTAAAGC 3'; COX-2: forward: 5'
GACAGTCCA CCAACTTACAAT 3', reverse: 5'
CATCTCTCCATCAATTATCTGAT 3'; GAPDH: forward: 5'
GTCGGTGTGAACGGATTT 3', reverse: 5' ACTCCAC-
GACGTACTCAGC 3', with the product sizes 292 bp, 411
bp and 276 bp, respectively. The condition of PCR reac-
tions was used as follows: 94°C for 5 min, then 94°C for
1 min; 63°C for COX-1, 56°C for COX-2 and 57°C for
GAPDH for 1 min; 72°C for 45 s for 30 cycles (GAPDH)
or 40 cycles (COX-1, 2) and 72°C for 10 min to end the
reaction. PCR products were electrophoresed by 1.5% aga-
rose gel containing ethidium bromide.
Quantitative reverse transcription-polymerase chain 
reaction (Q-PCR)
Total RNA was isolated by using Trizol Reagent (Invitro-
gen), and the reverse transcription reaction was conducted
with TaqMan reverse transcription reagents (Applied Bio-
systems). PCR amplications were performed by using
SYBR Green universal master mix for human and mouse
COX-2. Reactions were amplified and quantified by using
as ABI 7500 sequence detector. Relative quantity of
mRNAs were obtained by using the comparative Ct
method and was normalized by using TaqMan predevel-
oped assay reagent human cyclophilin and mouse
GAPDH for human COX-2 and mouse COX-2, respec-
tively. The primers for human COX-2 were as follows: for-
ward: 5'GAATCATTCACCAGGCAAATTG 3' and reverse: 5'
TCTGTA CTGCGGGTGGAA CA 3'. The primers for mouse
COX-2 were as follows: forward: 5' CCAGCACTTCAC
CCATCAGTT 3' and reverse: 5' ACCCAGGTCCTCGCT-
TATGA 3'.
Western blot
A549 were harvested by scrapers after stimulation of 15
min and 30 min. The cell pellets were lysed in lysis buffer
(125 mM Tris, pH 6.8, 4% SDS, 20% glycerol, 100 mM
dithiothreitol, and 0.5% bromophenol blue) and heated
for 5 min at 95°C. Electrophoresis was performed at 200
V for 1 h with 12% SDS-PAGE at room temperature. Pro-
teins were transferred to nitrocellulose membrane at 75 V
for 1.5 h by wet blot at 4°C in Mini-Protein (Bio-Rad, Cal-
ifornia, USA). The membrane was then blocked with 5%
non-fat dried milk in T-TBS for 1 h, washed three times
with T-TBS and incubated with phospho-p38 MAPK anti-
body (Cell Signaling, Bevery, USA) at 4°C overnight. The
blots were washed three times with T-TBS and incubated
for 1 h with HRP-conjugated goat-anti-rabbit IgG (Cell
Signaling) at room temperature. Immunoreactive bands
were developed using an ECL chemiluminescent substrate
(Pierce, Rockford, USA). Autoradiography was performed
with optimized exposure times. Accordingly, p38 MAPK
(Cell Signaling) was detected simultaneously to confirm
equal protein load.
Electrophoretic mobility shift assay (EMSA)
After stimulation of A549 cells, nuclear protein was iso-
lated using NE-PER Nuclear and Cytoplasmic Extraction
Reagents (Pierce). Biotin-labeled consensus NF-kappa B
oligonucleotides were purchased from Invitrogen (Shang-
hai, China). The sequence of oligo was: 5' AGTTGAG-
GGGACTTTCCCAGGC 3'. Briefly, EMSA binding
reactions were performed by incubating 5 µg of nuclear
extract with the annealed oligos according to the manu-
facturer's instructions (Lightshift EMSA Kit, Pierce). The
reaction mixture was subjected to electrophoresis on a 5%
native gel.
Enzyme linked immunosorbent assay (ELISA)
PGE2 level in cell supernatants was measured using com-
mercially available kits (R&D Systems) according to the
manufacturer's protocol. The limit of PGE2 assay was 39–
5000 pg/ml.
Statistical analysis
All data were presented as means ± SEM. One-way
ANOVA was used for statistical analysis of the differences
between the groups. A value of P < 0.05 was considered
statistically significant.
Results
NTHi-induced COX-2 expression in A549 cells
A549 cells were inoculated with NTHi at a MOI between
1 and 50 for 4 h, and RT-PCR analysis performed for the
mRNA expression. As shown in Fig. 1, NTHi inoculation
dose-dependently induced expression of COX-2 mRNA,
whereas had no effect on COX-1 mRNA in A549 cells.
PGE2 release from NTHi-stimulated A549 cells in a COX-
2 dependent way
To investigate the role of NTHi-induced COX-2 expression
on the PGE2 production, A549 cells, first, were inoculated
with NTHi at a MOI between 1 and 50 for 16 h, and PGE2Respiratory Research 2008, 9:16 http://respiratory-research.com/content/9/1/16
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expression was measured using ELISA assay. Result dem-
onstrated that PGE2 release from A549 cells was signifi-
cantly increased by NTHi (Fig. 2). Furthermore, the pre-
treatment of selective COX-2 inhibitor NS398 signifi-
cantly decreased NTHi-induced PGE2 production to base-
line levels, but pre-treatment of selective COX-1 inhibitor
SC560 has no effect on NTHi-induced PGE2 release in
lung epithelial cells A549. Taken together, these data indi-
cate that NTHi-induced PGE2 production was mediated
by COX-2 dependent pathway, but independently from
COX-1 pathway.
NTHi-induced COX-2 expression mediated by TLR2 
signaling pathway
Given the fact that TLR2 and TLR4 are of particular impor-
tant in NTHi-induced signaling pathway and gram-nega-
tive bacteria-initiated signaling pathway in lung epithelial
cells, respectively, we investigated the possible involve-
ment of TLR2 and TLR4 in NTHi-induced COX-2 expres-
sion in vitro by using HEK293 cells overexpressing TLR2 or
TLR4. As shown in Fig. 3A, NTHi-induced COX-2 expres-
sion was significantly enhanced by overexpressing TLR2,
but not by overexpressing TLR4. To further investigate the
role of TLR2 and TLR4 in NTHi-induced COX-2 expres-
sion in vivo, wild type, and TLR2 and TLR4 knock-out mice
were intratracheally inoculated with 1 × 107 CFU of NTHi
strain 12, and mRNA expression of COX-2 in lungs of
infected mice were measured by Q-PCR analysis 6 h after
inoculation. As shown in Fig. 3B, NTHi induced COX-2
expression in lung tissues of wild-type mice, and NTHi-
induced COX-2 expression was abolished by TLR2-defi-
ciency in TLR2 knock-out mice, but not by TLR4-defi-
ciency in TLR4 knock-out mice. Taken together, these data
indicate that NTHi-induced COX-2 expression is medi-
ated by TLR2-dependent pathway, but independently
from TLR4.
p38 MAPK instantly activated by NTHi
To investigate the involvement of p38 MAPK signaling
pathway, which is known as important component of
TLR2-induced signaling pathway, NTHi-induced phos-
phorylation of p38 MAPK was, first, measured by using
western blot analysis. As shown in Fig. 4A, the phosphor-
ylation of p38 MAPK was induced within 15–30 min in
A549 cells after NTHi inoculation, and the pre-treatment
of the specific inhibitor of p38 MAPK SB203580 blocked
p38 MAPK signaling activated by NTHi (Fig. 4B).
Up-regulation of NF-kappa B DNA binding activity after 
NTHi stimulation
Since NF-kappa B signaling pathway is known as a com-
ponent of TLR2 signaling pathway and down-stream of
p38 signaling pathway, we investigated whether NTHi
induces NF-kappa B activation in our system, and p38
MAPK is up-stream molecule of NTHi-induced NF-kappa
B signaling pathway. EMSA analysis showed that NF-
kappa B translocation and its DNA binding activity were
markedly increased by NTHi within 90 mins, and DNA
binding activity of NF-kappa B was not affected by pre-
treatment of specific p38 MAPK inhibitor SB203580.
These data indicate that p38 MAPK and NF-kappa B are
two independent signal pathways in the regulation of host
response of human lung epithelium against NTHi (Fig. 5).
NTHi-induced PGE2 expression mediated by COX-2 up-reg- ulation Figure 2
NTHi-induced PGE2 expression mediated by COX-2 
up-regulation. A549 cells were inoculated with different 
concentrations of NTHi with or without SC560 (5 µM) and 
NS398 (10 µM), specific inhibitors of COX-1 and COX-2, 
and expression levels of PGE2 were measured by ELISA 
assay. Data are means ± SEM (n = 4), *p < 0.05 vs. Mock 
group; **p < 0.05 vs. NTHi group at 50 MOI.
The mRNA expression of COX-2 but not COX-1 induced  by NTHi in a dose-dependent manner Figure 1
The mRNA expression of COX-2 but not COX-1 
induced by NTHi in a dose-dependent manner. A549 
cells were inoculated with different concentrations of NTHi, 
as indicated in the figure, and mRNA expression of COX-1 
and COX-2 was measured by RT-PCR analysis.Respiratory Research 2008, 9:16 http://respiratory-research.com/content/9/1/16
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NTHi-induced COX-2 and PGE2 expression mediated by 
p38 MAPK and NF-kappa B signaling pathway
To determine the role of NTHi-induced p38 MAPK and
NF-kappa B activations in NTHi-induced COX-2 and
PGE2 expression, the effects of p38 MAPK inhibitors
SB203580 and SB202190 and NF-kappa B inhibitor
PDTC on the NTHi-induced COX-2 mRNA expression
and PGE2 production were measured by using RT-PCR
analysis and ELISA assay, respectively. As shown in Fig. 6A
&6B, NTHi-induced COX-2 mRNA expression was mark-
edly inhibited by pre-treatment of NF-kappa B inhibitor
PDTC and p38 MAPK inhibitors SB203580 and
COX-2 up-regulation mediated by TLR2 in epithelial cells in vitro and lung tissues of mice in vivo Figure 3
COX-2 up-regulation mediated by TLR2 in epithelial cells in vitro and lung tissues of mice in vivo. A. HEK293 
cells overexpressing pcDNA, TLR2, and TLR4 were inoculated with NTHi, and COX-2 mRNA expression was measured by 
Q-PCR analysis. Data are means ± SEM (n = 3). *p < 0.05 vs. CON; **p < 0.005 vs. NTHi in HEK293-pcDNA. NS:non-signifi-
cant vs. NTHi in HEK293-pcDNA; CON: control. B: Wild-type and TLR2 and TLR4 knock-out mice were intratracheally inoc-
ulated with 1 × 107 CFU of NTHi, and mRNA expression of COX-2 was measured from the lungs of inoculated mice 6 h after 
inoculation. Data are means ± SEM (n = 3). *p < 0.05 vs. CON in wild-type mice; **p < 0.05 vs. NTHi in wild-type mice. NS: 
non-significant vs. NTHi in wild-type mice; CON: control.Respiratory Research 2008, 9:16 http://respiratory-research.com/content/9/1/16
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SB202190. Moreover, ELISA assay against PGE2 showed
that NTHi-induced PGE2 expression was significantly
inhibited by NF-kappa B inhibitor PDTC and p38 MAPK
inhibitors SB203580 and SB202190. Taken together,
these data clearly showed that NTHi-induced PGE2
expression is mediated by p38 MAPK- and NF-kappa B-
dependent signaling pathway (Fig. 6C).
Discussion
Although NTHi is an important respiratory pathogen in
both children and adults, little is known about its molec-
ular interaction with human lung epithelial cells.
Equipped with transmembranous and cytosolic pattern
recognition receptors, respiratory epithelium actively par-
ticipates in immune reaction against invading pathogens
instead of being only a passive physical barrier [10]. It has
been shown that Streptococcus pneumoniae,  Chlamydia
pneumoniae, Moraxella catarrhalis, and respiratory syncytial
virus induced COX-2 expression in pulmonary epithe-
NTHi-induced COX-2 mRNA and PGE2 expression medi- ated by p38 MAPK- and NF-kappa B-dependent signaling  pathway Figure 6
NTHi-induced COX-2 mRNA and PGE2 expression 
mediated by p38 MAPK- and NF-kappa B-dependent 
signaling pathway. A: A549 cells were inoculated with 
NTHi with or without PDTC, and COX-2 mRNA expression 
was measured by RT-PCR analysis 4 h after NTHi inocula-
tion. B: A549 cells were inoculated with p38 inhibitors 
SB203580 or SB202190, and COX-2 mRNA expression was 
measured by RT-PCR analysis 4 h after NTHi inoculation. C: 
A549 cells were inoculated with NTHi with or without 
PDTC, SB203580, and SB202190, and expression levels of 
PGE2 were measured by ELISA assay 16 h after NTHi inocu-
lation. Data are means ± SEM (n = 3). *p < 0.05 vs. Mock; **p 
< 0.05 vs. 50 MOI of NTHi.
A           
N T H i       -       +       +           
        P D T C       -       -       +           
COX-2
 GAPDH
COX-2/GAPDH   0.11   0.49    0.16   
B
N T H i        -       +      +      +    
S B 2 0 3 5 8 0       -       -       +      -   
S B 2 0 2 1 9 0       -       -       -      +   
COX-2   
GAPDH
COX-2/GAPDH     0.10   0.62   0.22   0.21 
C  
N T H i       -        +         +        +        +
    P D T C      -         -         +        -        -  
 S B 2 0 3 5 8 0      -        -          -        +        -  
S B 2 0 2 1 9 0      -        -          -        -        +    
Phosphorylation of p38 MPAK induced by NTHi Figure 4
Phosphorylation of p38 MPAK induced by NTHi. A. 
A549 cells were inoculated with 10 and 50 MOI of NTHi, 
and phosphorayltion of p38 MAPK was detected by Immuno-
blot analysis. B: A549 cells were inoculated with 50 MOI of 
NTHi with or without 20 µM of SB203580, and phosphorayl-
tion of p38 MAPK was detected by Immunoblot analysis. A & 
B: representative blots from three independent experiments.
Enhanced DNA binding activity of NF-kappa B induced by  NTHi Figure 5
Enhanced DNA binding activity of NF-kappa B 
induced by NTHi. A549 cells were incubated with different 
concentrations of NTHi with or without SB203580, and 
DNA binding activity of NF-kappa B was measured by EMSA 
analysis. A representative gel from three independent exper-
iments with similar results is shown in figure.Respiratory Research 2008, 9:16 http://respiratory-research.com/content/9/1/16
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lium [9,11-13]. However, whether NTHi infections have
effect on the expression of COX-2 and subsequent PGE2
in lung epithelial cells still remains uncertain.
Lipid products of arachidonic acid including prostagland-
ins play important roles in pulmonary immune regula-
tion. PGE2 released by lung cells is demonstrated as a
potent endogenous anti-inflammatory mediator, which
modulates host immune response [7]. But, data about the
molecular mechanisms of pulmonary PGE2 expression
are very limited. In the present study, we demonstrated
that NTHi induced COX-2 mRNA but not COX-1 mRNA
in a dose-dependent manner in A549 cells. Furthermore,
NTHi-induced PGE2 release was significantly suppressed
by COX-2 specific inhibitor, but not COX-1 inhibitor.
These results indicated that PGE2 release depends on
COX-2 activity, in line with the previous studies by
Schmeck et al. and Rupp et al. [9,14].
TLRs are well known cell surface receptors recognizing
invading microbes and initiating cellular signaling path-
ways against bacterial components. Among of 11 mam-
malian TLRs, TLR2 is recognized as an important receptor
for NTHi-induced signaling pathway in lung epithelial
cells. Taken advantages of stably overexpressing TLR2 and
TLR4 cells and TLR2 and TLR4 knock-out mice, we
showed here that NTHi-induced COX-2 expression was
mediated by TLR2 signaling pathway both in vitro and in
vivo, but independently from TLR4. These data are in line
with previous report that TLR2 is of particular important
receptor for NTHi components [15,16].
The lung epithelial cell signaling networks activated by
NTHi have been partially elucidated in recent years.
Among these signaling pathways, p38 MAPK and NF-
kappa B are two key molecules which coordinate the
induction of multiple genes encoding inflammatory
mediators and are involved in host immune responses to
NTHi infections [2]. Activation of p38 MAPK up-regulates
inflammatory cytokines, mucin MUC5AC and down-reg-
ulates TLR2 expression while activation of NF-kappa B
increases the expression of IL-8, IL-1β, mucin MUC2 and
TLR2 [15-19]. In addition, there exists an auto-regulation
of NF-kappa B activation: NF-kappa B is essential for
induction of cylindromatosis (CYLD) that in turn inhibits
NF-kappa B signaling [20]. However, whether p38 and
NF-kappa B are involved in COX-2 and PGE2 production
induced by NTHi remained unclear. Herein, we showed
that NTHi activated the phosphorylation of p38 MAPK
and nuclear translocation of NF-kappa B within 90 mins,
and the enhanced DNA binding activity was observed in
nuclear extracts of A549 cells after NTHi inoculation.
NTHi-induced COX-2 mRNA expression was markedly
inhibited not only by p38 MAPK inhibitor SB203580, but
also by another p38 MAPK inhibitor SB202190, and NF-
kappa B inhibitor PDTC. Moreover, PGE2 release by
NTHi, also, was significantly reduced by both p38 MAPK
inhibitors and NF-kappa B inhibitor. The findings in the
present study clearly demonstrate that the activation of
p38 MAPK and NF-kappa B is involved in the regulation
of COX-2 and PGE2 in NTHi-infected lung epithelium.
In this study, we found the impact of p38 MAPK on the
activation of NF-kappa B. EMSA results showed that the
NF-kappa B activation was not prevented by SB203580 in
infected A549 cells, indicating that p38 MAPK and NF-
kappa B are independent pathways regulating PGE2
expression in our experimental systems. Mancuso et al.
reported that neither p38 nor ERK MAPK blockade had
any effect on Group B streptococci (GBS)-induced NF-
kappa B binding activity [21]. Vallejo et al. demonstrated
that p38 inhibitor SB202190 inhibited GBS-induced acti-
vator protein (AP)-1-DNA activity, but did not prevent
NF-kappa B activation [22]. Similarly, the study by Singer
et al. showed that p38 MAPK and NF-kappa B may affect
COX-2 expression in human airway myocytes via separate
signaling pathways given the fact that SB203580 did not
affect cytokine-stimulated IkappaBalpha degradation and
NF-kappa B nuclear binding activity [23]. However, the
above results cannot exclude another possibility that there
exists an indirect cross-talk between p38 MAPK and NF-
kappa B which converge further down in the signal cas-
cades [21]. Indeed, there are still increasing evidences that
the blockade of MAPK inhibited NF-kappa B-dependent
gene transcription without affecting IkappaBalpha phos-
phorylation and NF-kappa B-DNA binding ability [9,24-
27].
In our study, the fold induction of NTHi-induced PGE2
production was relatively low compared with those from
other studies conducted by using S. pneumoniae or  C.
pneumoniae infection model [9,14], possibly due to the
different signaling pathways mediated. However, the
absolute amount of PGE2 production measured in our
study in lung epithelial cells A549 is quite equivalent to
those from other studies [28,29]. In addition to this, little
is known about the patho-physiological role of the pros-
tanoid intermediates including PGE2 in NTHi infections
due to the absence of research information in this field.
Thus, even though we could not rule the involvement of
other prostanoid intermediates such as PGF and PGI in
NTHi infections, we suggest here that NTHi-induced
PGE2 may play an important role in NTHi infection. Fur-
ther studies in the detailed molecular mechanisms under-
lying NTHi-induced PGE2 expression and in the
pathological analysis of the role of PGE2 in NTHi infec-
tion based on the findings from present study will bring
us novel insights into the therapeutic strategies of pulmo-
nary NTHi infections.Respiratory Research 2008, 9:16 http://respiratory-research.com/content/9/1/16
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Conclusion
In conclusion, NTHi induces COX-2 and PGE2 expression
in a p38 MAPK and NF-kappa B-dependent manner
through TLR2 in lung epithelial cells in vitro and lung tis-
sues in vivo. The full understanding of the role of endog-
enous anti-inflammatory PGE2 and its regulation will
bring new insight to the resolution of inflammation in
pulmonary NTHi infections.
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